Related Experiment Video
Updated: Dec 6, 2025

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
Published on: April 19, 2019
A novel personalized approach to cardiovascular prevention: The VIVOPTIM programme
Jacques Blacher1, Virginie Femery2, Florence Thorez3
1Paris-Descartes University, AP-HP, Diagnosis and Therapeutic Center, Hôtel-Dieu University Hospital, Paris, France.
The VIVOPTIM program, a digital health initiative, significantly improved cardiovascular health by reducing blood pressure, weight, and smoking, while increasing daily steps. This program shows potential for widespread impact on patient care in France.
Area of Science:
- Digital Health
- Cardiovascular Disease Prevention
- Health Management
Background:
- Cardiovascular diseases represent a major cause of mortality globally.
- A significant portion of cardiovascular diseases are preventable through lifestyle modifications and proactive health management.
- The Mutuelle générale de l'éducation nationale (MGEN) developed the VIVOPTIM program to address this challenge.
Purpose of the Study:
- To evaluate the effectiveness of the VIVOPTIM program, a novel digital healthcare approach.
- To assess the impact of individualized, multiprofessional, and ranked management of cardiovascular risk factors.
- To determine the program's potential for improving patient care and healthcare system organization in France.
Main Methods:
- A pilot program involving 2240 participants aged 30-70 in France.
- Participants completed a Framingham Heart Study Risk Score questionnaire to determine cardiovascular risk levels.
- The VIVOPTIM program included risk assessment, education, personalized telephone coaching, and e-Health monitoring.
Main Results:
- Significant reductions in mean systolic blood pressure (-3.4mmHg) and weight (-1.5kg).
- A notable decrease in daily cigarette consumption (-2.2 cigarettes/day).
- A significant increase in daily steps taken (+1726 steps/day).
Conclusions:
- The VIVOPTIM program demonstrated positive mid-to-long-term results in improving key cardiovascular health indicators.
- The program's success led to its expansion across France in 2018.
- VIVOPTIM holds significant potential to enhance patient care and optimize healthcare system organization.
Related Concept Videos
Coronary Artery Disease IV: Preventive Measures
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Coronary Artery Disease V: Interprofessional Care
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Cardiovascular Drugs: Classification based on Therapeutic Indications
Hypertension IV: Drug Therapy and Lifestyle Modifications

